Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lonidamine: Angelini's anticancer agent has been approved for marketing in Italy

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Lonidamine: Angelini's anticancer agent has been approved for marketing in Italy. Inpharma Wkly. 583, 19 (1987). https://doi.org/10.1007/BF03291319

    Download citation

    Keywords

    • Renal Cell Carcinoma
    • Gossypol
    • Papillary Carcinoma
    • Molecular Pathology
    • Lymphoid Leukemia